Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Design, synthesis, and antiprotozoal evaluation of new 2,4-bis[(substituted-aminomethyl)phenyl]quinoline, 1,3-bis[(substituted-aminomethyl)phenyl]isoquinoline and 2,4-bis[(substituted-aminomethyl)phenyl]quinazoline derivatives.

Guillon J, Cohen A, Boudot C, Valle A, Milano V, Das RN, Guédin A, Moreau S, Ronga L, Savrimoutou S, Demourgues M, Reviriego E, Rubio S, Ferriez S, Agnamey P, Pauc C, Moukha S, Dozolme P, Nascimento SD, Laumaillé P, Bouchut A, Azas N, Mergny JL, Mullié C, Sonnet P, Courtioux B.

J Enzyme Inhib Med Chem. 2020 Dec;35(1):432-459. doi: 10.1080/14756366.2019.1706502.

2.

Peptide-Based Drug-Delivery Systems in Biotechnological Applications: Recent Advances and Perspectives.

Tesauro D, Accardo A, Diaferia C, Milano V, Guillon J, Ronga L, Rossi F.

Molecules. 2019 Jan 19;24(2). pii: E351. doi: 10.3390/molecules24020351. Review.

3.

Design, Synthesis and Biological Evaluation of New Substituted Diquinolinyl-Pyridine Ligands as Anticancer Agents by Targeting G-Quadruplex.

Das RN, Chevret E, Desplat V, Rubio S, Mergny JL, Guillon J.

Molecules. 2017 Dec 30;23(1). pii: E81. doi: 10.3390/molecules23010081.

4.

Design, synthesis, and antiprotozoal evaluation of new 2,9-bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline derivatives.

Guillon J, Cohen A, Das RN, Boudot C, Gueddouda NM, Moreau S, Ronga L, Savrimoutou S, Basmaciyan L, Tisnerat C, Mestanier S, Rubio S, Amaziane S, Dassonville-Klimpt A, Azas N, Courtioux B, Mergny JL, Mullié C, Sonnet P.

Chem Biol Drug Des. 2018 May;91(5):974-995. doi: 10.1111/cbdd.13164. Epub 2018 Jan 17.

PMID:
29266861
5.

Synthesis and Antimalarial Activity of New Enantiopure Aminoalcoholpyrrolo[ 1,2-a]quinoxalines.

Jonet A, Guillon J, Mullie C, Cohen A, Bentzinger G, Schneider J, Taudon N, Hutter S, Azas N, Moreau S, Savrimoutou S, Agnamey P, Dassonville-Klimpt A, Sonnet P.

Med Chem. 2018;14(3):293-303. doi: 10.2174/1573406413666170726123938.

PMID:
28745231
6.

Synthesis and Antiproliferative Effect of Ethyl 4-[4-(4-Substituted Piperidin-1-yl)]benzylpyrrolo[1,2-a]quinoxalinecarboxylate Derivatives on Human Leukemia Cells.

Desplat V, Vincenzi M, Lucas R, Moreau S, Savrimoutou S, Rubio S, Pinaud N, Bigat D, Enriquez E, Marchivie M, Routier S, Sonnet P, Rossi F, Ronga L, Guillon J.

ChemMedChem. 2017 Jun 21;12(12):940-953. doi: 10.1002/cmdc.201700049. Epub 2017 Apr 5.

PMID:
28218826
7.

Design, synthesis and antimalarial activity of novel bis{N-[(pyrrolo[1,2-a]quinoxalin-4-yl)benzyl]-3-aminopropyl}amine derivatives.

Guillon J, Cohen A, Gueddouda NM, Das RN, Moreau S, Ronga L, Savrimoutou S, Basmaciyan L, Monnier A, Monget M, Rubio S, Garnerin T, Azas N, Mergny JL, Mullié C, Sonnet P.

J Enzyme Inhib Med Chem. 2017 Dec;32(1):547-563. doi: 10.1080/14756366.2016.1268608.

8.

Design, Synthesis, and Evaluation of 2,9-Bis[(substituted-aminomethyl)phenyl]-1,10-phenanthroline Derivatives as G-Quadruplex Ligands.

Gueddouda NM, Hurtado MR, Moreau S, Ronga L, Das RN, Savrimoutou S, Rubio S, Marchand A, Mendoza O, Marchivie M, Elmi L, Chansavang A, Desplat V, Gabelica V, Bourdoncle A, Mergny JL, Guillon J.

ChemMedChem. 2017 Jan 20;12(2):146-160. doi: 10.1002/cmdc.201600511. Epub 2017 Jan 3.

9.

Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines.

Desplat V, Vincenzi M, Lucas R, Moreau S, Savrimoutou S, Pinaud N, Lesbordes J, Peyrilles E, Marchivie M, Routier S, Sonnet P, Rossi F, Ronga L, Guillon J.

Eur J Med Chem. 2016 May 4;113:214-27. doi: 10.1016/j.ejmech.2016.02.047. Epub 2016 Feb 20.

PMID:
26945110
10.

Diminished oligomerization in the synthesis of new anti-angiogenic cyclic peptide using solution instead of solid-phase cyclization.

Rubio S, Clarhaut J, Péraudeau E, Vincenzi M, Soum C, Rossi F, Guillon J, Papot S, Ronga L.

Biopolymers. 2016 May;106(3):368-75. doi: 10.1002/bip.22814.

PMID:
26832831
11.

Intrinsically disordered amphiphilic peptides as potential targets in drug delivery vehicles.

Vincenzi M, Accardo A, Costantini S, Scala S, Portella L, Trotta A, Ronga L, Guillon J, Leone M, Colonna G, Rossi F, Tesauro D.

Mol Biosyst. 2015 Nov;11(11):2925-32. doi: 10.1039/c5mb00358j.

PMID:
26263446
12.

Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and non-toxic inhibitors stimulating basal ATPase activity.

Gozzi GJ, Bouaziz Z, Winter E, Daflon-Yunes N, Honorat M, Guragossian N, Marminon C, Valdameri G, Bollacke A, Guillon J, Pinaud N, Marchivie M, Cadena SM, Jose J, Le Borgne M, Di Pietro A.

Drug Des Devel Ther. 2015 Jul 3;9:3481-95. doi: 10.2147/DDDT.S84982. eCollection 2015.

13.

Synthesis, Biological Evaluation and Molecular Modeling of Substituted Indeno[1,2-b]indoles as Inhibitors of Human Protein Kinase CK2.

Alchab F, Ettouati L, Bouaziz Z, Bollacke A, Delcros JG, Gertzen CG, Gohlke H, Pinaud N, Marchivie M, Guillon J, Fenet B, Jose J, Borgne ML.

Pharmaceuticals (Basel). 2015 Jun 8;8(2):279-302. doi: 10.3390/ph8020279.

14.

Conformational ensembles explored dynamically from disordered peptides targeting chemokine receptor CXCR4.

Vincenzi M, Costantini S, Scala S, Tesauro D, Accardo A, Leone M, Colonna G, Guillon J, Portella L, Trotta AM, Ronga L, Rossi F.

Int J Mol Sci. 2015 May 28;16(6):12159-73. doi: 10.3390/ijms160612159.

15.

Converting potent indeno[1,2-b]indole inhibitors of protein kinase CK2 into selective inhibitors of the breast cancer resistance protein ABCG2.

Jabor Gozzi G, Bouaziz Z, Winter E, Daflon-Yunes N, Aichele D, Nacereddine A, Marminon C, Valdameri G, Zeinyeh W, Bollacke A, Guillon J, Lacoudre A, Pinaud N, Cadena SM, Jose J, Le Borgne M, Di Pietro A.

J Med Chem. 2015 Jan 8;58(1):265-77. doi: 10.1021/jm500943z. Epub 2014 Oct 16.

PMID:
25272055
16.

Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents--part III.

Ronga L, Del Favero M, Cohen A, Soum C, Le Pape P, Savrimoutou S, Pinaud N, Mullié C, Daulouede S, Vincendeau P, Farvacques N, Agnamey P, Pagniez F, Hutter S, Azas N, Sonnet P, Guillon J.

Eur J Med Chem. 2014 Jun 23;81:378-93. doi: 10.1016/j.ejmech.2014.05.037. Epub 2014 May 14.

PMID:
24858543
17.

Structural elucidation of two photolytic degradation products of tetrabenazine.

Bourezg Z, Cartiser N, Ettouati L, Guillon J, Lacoudre A, Pinaud N, Le Borgne M, Fessi H.

J Pharm Biomed Anal. 2014 Mar;91:138-43. doi: 10.1016/j.jpba.2013.12.032. Epub 2014 Jan 3.

PMID:
24457996
18.

1H and 13C NMR assignments of bioactive indeno[1,2-b]indole-10-one derivatives.

Al Chab F, Fenet B, Le Borgne M, Jose J, Pinaud N, Guillon J, Ettouati L.

Magn Reson Chem. 2013 Dec;51(12):837-41. doi: 10.1002/mrc.4016. Epub 2013 Oct 2.

PMID:
24123338
19.

tert-Butyl N-{[5-(5-oxohexa-namido)-pyridin-2-yl]amino}-carbamate.

Ronga L, Pinaud N, Rimbault C, Marchivie M, Guillon J.

Acta Crystallogr Sect E Struct Rep Online. 2013 Sep 12;69(Pt 10):o1531-2. doi: 10.1107/S1600536813024598. eCollection 2013.

20.

Absolute Configuration and Antimalarial Activity of erythro-Mefloquine Enantiomers.

Dassonville-Klimpt A, Cézard C, Mullié C, Agnamey P, Jonet A, Da Nascimento S, Marchivie M, Guillon J, Sonnet P.

Chempluschem. 2013 Jul;78(7):642-646. doi: 10.1002/cplu.201300074. Epub 2013 Jun 21.

PMID:
31986621

Supplemental Content

Loading ...
Support Center